0001209191-14-059536.txt : 20140924
0001209191-14-059536.hdr.sgml : 20140924
20140924112047
ACCESSION NUMBER: 0001209191-14-059536
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140924
FILED AS OF DATE: 20140924
DATE AS OF CHANGE: 20140924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vitae Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001157602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 502 WEST OFFICE CENTER DR
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
BUSINESS PHONE: 215-461-2000
MAIL ADDRESS:
STREET 1: 502 WEST OFFICE CENTER DR
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
FORMER COMPANY:
FORMER CONFORMED NAME: Vitae Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050118
FORMER COMPANY:
FORMER CONFORMED NAME: CONCURRENT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VEF MANAGEMENT III LLC
CENTRAL INDEX KEY: 0001239246
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36617
FILM NUMBER: 141117702
MAIL ADDRESS:
STREET 1: C/O VENROCK ASSOCIATES
STREET 2: 30 ROCKFELLER PLACA RM 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VENROCK ENTREPRENEURS FUND III LP
CENTRAL INDEX KEY: 0001141515
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36617
FILM NUMBER: 141117703
BUSINESS ADDRESS:
STREET 1: C/O VENROCK ASSOCIATES ROOM 5508
STREET 2: 30 ROCKEFELLER PLAZA
CITY: NEW YORK
STATE: NY
ZIP: 10112
BUSINESS PHONE: 212-649-5600
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VENROCK ASSOCIATES
CENTRAL INDEX KEY: 0000937889
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36617
FILM NUMBER: 141117704
BUSINESS ADDRESS:
STREET 1: ROOM 5508
STREET 2: 30 ROCKEFELLER PLAZA
CITY: NEW YORK
STATE: NY
ZIP: 10112
BUSINESS PHONE: 2126495600
MAIL ADDRESS:
STREET 1: ROOM 5508
STREET 2: 30 ROCKEFELLER PLAZA
CITY: NEW YORK
STATE: NY
ZIP: 10112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VENROCK ASSOCIATES III LP
CENTRAL INDEX KEY: 0001119517
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36617
FILM NUMBER: 141117705
BUSINESS ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA
STREET 2: RM 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VENROCK MANAGEMENT III LLC
CENTRAL INDEX KEY: 0001239247
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36617
FILM NUMBER: 141117706
MAIL ADDRESS:
STREET 1: C/O VENROCK ASSOCIATES
STREET 2: 30 ROCKFELLER PLACA RM 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2014-09-24
0
0001157602
Vitae Pharmaceuticals, Inc
VTAE
0001239247
VENROCK MANAGEMENT III LLC
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
0
0
1
0
0001119517
VENROCK ASSOCIATES III LP
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
0
0
1
0
0000937889
VENROCK ASSOCIATES
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
0
0
1
0
0001141515
VENROCK ENTREPRENEURS FUND III LP
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
0
0
1
0
0001239246
VEF MANAGEMENT III LLC
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
0
0
1
0
Series A-2 Preferred Stock
Common Stock
48333
I
See Footnote
Series A-2 Preferred Stock
Common Stock
214820
I
See Footnote
Series A-2 Preferred Stock
Common Stock
5367
I
See Footnote
Series B Preferred Stock
Common Stock
227117
I
See Footnote
Series B Preferred Stock
Common Stock
1009414
I
See Footnote
Series B Preferred Stock
Common Stock
25233
I
See Footnote
Series C Preferred Stock
Common Stock
9285
I
See Footnote
Series C Preferred Stock
Common Stock
41270
I
See Footnote
Series C Preferred Stock
Common Stock
1031
I
See Footnote
Each share of Series A-2 Preferred Stock will automatically convert on a 1:1.50638118 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date.
The reportable securities are owned by Venrock Associates.
The reportable securities are owned by Venrock Associates III, L.P. ("VA III"). Venrock Management III, LLC ("VM III") is the general partner of VA III. VM III disclaims beneficial ownership of these securities and this report shall not be deemed an admission that it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
The reportable securities are owned by Venrock Entrepreneurs Fund III, L.P. ("VEF III"). VEF Management III, LLC ("VEFM III") is the general partner of VEF III. VEFM III disclaims beneficial ownership of these securities and this report shall not be deemed an admission it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
Each share of Series B Preferred Stock and Series C Preferred Stock will automatically convert on a 1:1 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date.
/s/ David L. Stepp, Authorized Signatory, Venrock Associates III, L.P.
2014-09-24
/s/ David L. Stepp, Authorized Signatory, Venrock Associates
2014-09-24
/s/ David L. Stepp, Authorized Signatory, Venrock Entrepreneurs Fund III, L.P.
2014-09-24
/s/ David L. Stepp, Authorized Signatory, Venrock Management III, LLC
2014-09-24
/s/ David L. Stepp, Authorized Signatory, VEF Management III, LLC
2014-09-24